Showing results (71-80 of 500) with videos related to
Sort By:
Pageof 50
The Journal of Experimental Medicine|August 1, 1985
Evidence for a regulatory idiotypic network in the in vivo response to H-2 antigensR Rabinowitz, J A Bluestone, D H SachsNature Reviews. Immunology|December 8, 2019
Treg cell-based therapies: challenges and perspectivesCaroline Raffin, Linda T Vo, Jeffrey A BluestoneTrends in Immunology|March 14, 2021
Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting CytokinesJee Hye Kang, Jeffrey A Bluestone, Arabella YoungJournal of Molecular Cell Biology|December 16, 2011
CD4(+)Foxp3(+) regulatory T cell therapy in transplantationQizhi Tang, Jeffrey A Bluestone, Sang-Mo KangThe Journal of Experimental Medicine|June 1, 1993
Tolerance of T cell receptor gamma/delta cells in the intestineT A Barrett, Y Tatsumi, J A BluestoneAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospectsS M Kang, Q Tang, J A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
B7-independent inhibition of T cells by CTLA-4Shunsuke Chikuma, Abul K Abbas, Jeffrey A BluestoneGenome Medicine|November 1, 2018
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back againSamantha L Bucktrout, Jeffrey A Bluestone, Fred RamsdellAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 20, 2003
Clinical trials of transplant tolerance: slow but steady progressJeffrey B Matthews, Eleanor Ramos, Jeffrey A BluestoneThe Journal of Experimental Medicine|June 13, 1998
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptorL A Chau, J A Bluestone, J MadrenasPageof 50